The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 04, 2018

Filed:

May. 20, 2014
Applicant:

Cardiac Pacemakers, Inc., St. Paul, MN (US);

Inventors:

Robert J. Sweeney, Woodbury, MN (US);

Yi Zhang, Plymouth, MN (US);

Qi An, Blaine, MN (US);

Pramodsingh Hirasingh Thakur, Woodbury, MN (US);

Assignee:

Cardiac Pacemakers, Inc., St. Paul, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/02 (2006.01); A61B 5/0205 (2006.01); A61B 5/08 (2006.01); A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61B 5/20 (2006.01); A61B 5/024 (2006.01); A61B 5/0245 (2006.01); G06F 19/00 (2018.01);
U.S. Cl.
CPC ...
A61B 5/0205 (2013.01); A61B 5/024 (2013.01); A61B 5/02028 (2013.01); A61B 5/0245 (2013.01); A61B 5/08 (2013.01); A61B 5/0826 (2013.01); A61B 5/14532 (2013.01); A61B 5/201 (2013.01); A61B 5/4818 (2013.01); A61B 5/7275 (2013.01); A61B 5/7282 (2013.01); G06F 19/00 (2013.01); A61B 5/0031 (2013.01);
Abstract

Devices and methods for identifying patient at elevated risk of developing future heart failure (HF) events, such as events indicative of HF decompensation status, are described. The devices and methods can stratify the risk using sensor signals or signal metrics selected in accordance with patient chronic conditions. A medical device can receive a patient status input including at least a first and a second chronic condition indicators, sense one or more physiologic signals from the patient, and generate a plurality of signal metrics from the physiologic signals when the first chronic condition indicator and the second chronic condition indicator meets respective criterion. One or more patient-specific signal metrics can be selected from a group including the signal metrics selected for both the first and the second chronic conditions. A risk stratification algorithm can use the selected one or more patient-specific signal metrics to compute a composite risk index indicative of the probability of the patient later developing an event indicative of worsening of HF.


Find Patent Forward Citations

Loading…